Literature DB >> 25918178

Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.

Namisha Singh1, Sonja Gandhi1, Eric McArthur1, Louise Moist1, Arsh K Jain1, Aiden R Liu1, Manish M Sood1, Amit X Garg2.   

Abstract

BACKGROUND: The antibiotic nitrofurantoin is commonly used to treat uncomplicated urinary tract infections. However, when this drug is used by patients with reduced kidney function, its urine concentration may be subtherapeutic.
METHODS: We conducted a population-based study of older women (mean age 79 years) in Ontario, Canada, whose estimated glomerular filtration rate was relatively low (median 38 mL/min per 1.73 m(2)) and for whom 1 of 4 antibiotics had been prescribed for urinary tract infection: nitrofurantoin, ciprofloxacin, norfloxacin or trimethoprim-sulfamethoxazole. We assessed 2 measures of treatment failure in the subsequent 14 days: receipt of a second antibiotic indicated for urinary tract infection and hospital encounter (emergency department visit or hospital admission) with a urinary tract infection. We repeated the analysis for older women with relatively high estimated glomerular filtration rate (median 69 mL/min per 1.73 m(2)).
RESULTS: The baseline characteristics of the 4 antibiotic groups were similar. Relative to nitrofurantoin, the other antibiotics (including ciprofloxacin) were associated with a lower rate of treatment failure among women with relatively low estimated glomerular filtration rate (for ciprofloxacin v. nitrofurantoin: second antibiotic prescription, 130/1989 [6.5%] v. 516/3739 [13.8%], odds ratio [OR] 0.44, 95% confidence interval [CI] 0.36-0.53; hospital encounter, 21/1989 [1.1%] v. 95/3739 [2.5%], OR 0.41, 95% CI 0.25-0.66). However, a similar risk of treatment failure with nitrofurantoin was also observed among women with relatively high estimated glomerular filtration rate. The results were consistent in multiple additional analyses.
INTERPRETATION: In this study, the presence of mild or moderate reductions in estimated glomerular filtration rate did not justify avoidance of nitrofurantoin.
© 2015 Canadian Medical Association or its licensors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25918178      PMCID: PMC4467927          DOI: 10.1503/cmaj.150067

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  23 in total

1.  The management of urinary infections: what have we learned in the past decade?

Authors:  G K Harding; A R Ronald
Journal:  Int J Antimicrob Agents       Date:  1994-06       Impact factor: 5.283

2.  Altered mental status in older adults with histamine2-receptor antagonists: a population-based study.

Authors:  Davy Tawadrous; Stephanie Dixon; Salimah Z Shariff; Jamie Fleet; Sonja Gandhi; Arsh K Jain; Matthew A Weir; Tara Gomes; Amit X Garg
Journal:  Eur J Intern Med       Date:  2014-07-16       Impact factor: 4.487

3.  Effect of renal function on urinary recovery of orally administered nitrofurantoin.

Authors:  J Sachs; T Geer; P Noell; C M Kunin
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

4.  Current antibiotic therapy for isolated urinary tract infections in women.

Authors:  Alexander J Kallen; H Gilbert Welch; Brenda E Sirovich
Journal:  Arch Intern Med       Date:  2006-03-27

5.  Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Gary R Matzke; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Lesley A Inker; Jason G Umans; Patrick Murray
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

6.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

Review 7.  The pharmacokinetics of nitrofurantoin and its related bioavailability.

Authors:  J D Conklin
Journal:  Antibiot Chemother (1971)       Date:  1978

8.  Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Stephen B Porter; Connie Clabots; James R Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-13       Impact factor: 3.254

9.  Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes.

Authors:  Jamie L Fleet; Stephanie N Dixon; Salimah Z Shariff; Robert R Quinn; Danielle M Nash; Ziv Harel; Amit X Garg
Journal:  BMC Nephrol       Date:  2013-04-05       Impact factor: 2.388

10.  How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study.

Authors:  Daniel Pilsgaard Henriksen; Stig Lønberg Nielsen; Christian Borbjerg Laursen; Jesper Hallas; Court Pedersen; Annmarie Touborg Lassen
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more
  12 in total

1.  Nitrofurantoin and older women.

Authors:  Yildiray Topçu; Fatih Tufan; Gulistan Bahat; Akif Karan
Journal:  CMAJ       Date:  2015-11-03       Impact factor: 8.262

2.  How Common Are Pulmonary and Hepatic Adverse Effects in Older Adults Prescribed Nitrofurantoin?

Authors:  Karin Claussen; Edward Stocks; Deepa Bhat; Jason Fish; Craig D Rubin
Journal:  J Am Geriatr Soc       Date:  2017-03-17       Impact factor: 5.562

Review 3.  Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults.

Authors:  Nicolas W Cortes-Penfield; Barbara W Trautner; Robin L P Jump
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

4.  Membrane-Active Hydantoin Derivatives as Antibiotic Agents.

Authors:  Ma Su; Donglin Xia; Peng Teng; Alekhya Nimmagadda; Chao Zhang; Timothy Odom; Annie Cao; Yong Hu; Jianfeng Cai
Journal:  J Med Chem       Date:  2017-10-06       Impact factor: 7.446

Review 5.  Prescribing for patients on dialysis.

Authors:  Brendan Smyth; Ceridwen Jones; John Saunders
Journal:  Aust Prescr       Date:  2016-02-01

Review 6.  Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Authors:  Bradley J Gardiner; Andrew J Stewardson; Iain J Abbott; Anton Y Peleg
Journal:  Aust Prescr       Date:  2019-02-01

7.  Low Concordance With Guidelines for Treatment of Acute Cystitis in Primary Care.

Authors:  Larissa Grigoryan; Roger Zoorob; Haijun Wang; Barbara W Trautner
Journal:  Open Forum Infect Dis       Date:  2015-10-26       Impact factor: 3.835

8.  Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes.

Authors:  Sarah C J Jorgensen; Samantha L Yeung; Mira Zurayk; Jill Terry; Maureen Dunn; Paul Nieberg; Jean Pallares; Annie Wong-Beringer
Journal:  Open Forum Infect Dis       Date:  2018-05-02       Impact factor: 3.835

9.  Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data.

Authors:  Haroon Ahmed; Daniel Farewell; Nick A Francis; Shantini Paranjothy; Christopher C Butler
Journal:  PLoS Med       Date:  2018-09-10       Impact factor: 11.613

10.  Low antimicrobial resistance in general practice patients in Rotterdam, the city with the largest proportion of immigrants in the Netherlands.

Authors:  Maaike Honsbeek; Aimée Tjon-A-Tsien; Ellen Stobberingh; Jurriaan de Steenwinkel; Damian C Melles; Jan Lous; Jan Hendrik Richardus; Hélène Voeten
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.